Rhinitis medicamentosa – preventable disease
Aim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa. The comparative estimation of modern means of pharmacotherapy was made. On the basis of literat...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/4354 |
id |
doaj-1e090b9c49d7423d984867e620cfd28e |
---|---|
record_format |
Article |
spelling |
doaj-1e090b9c49d7423d984867e620cfd28e2021-07-28T13:29:43ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902019-11-01020273010.21518/2079-701X-2019-20-27-303903Rhinitis medicamentosa – preventable diseaseA. I. Kryukov0A. B. Turovskiy1I. G. Kolbanova2K. M. Musayev3A. B. Karasov4L.I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology; N.I. Pirogov Russian National Research Medical UniversityL.I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology; V.V. Veresaev Municipal Clinical HospitalL.I. Sverzhevsky Research Clinical Institute of OtorhinolaryngologyL.I. Sverzhevsky Research Clinical Institute of OtorhinolaryngologyL.I. Sverzhevsky Research Clinical Institute of OtorhinolaryngologyAim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa. The comparative estimation of modern means of pharmacotherapy was made. On the basis of literature and clinical research data, it is concluded that Otrivin has a much more gentle effect and contributes less to the development of rhinitis medicamentosa.https://www.med-sovet.pro/jour/article/view/4354rhinitis medicamentosanasal congestionotrivinnasal mucosa inflammationlocal decongestants |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
A. I. Kryukov A. B. Turovskiy I. G. Kolbanova K. M. Musayev A. B. Karasov |
spellingShingle |
A. I. Kryukov A. B. Turovskiy I. G. Kolbanova K. M. Musayev A. B. Karasov Rhinitis medicamentosa – preventable disease Медицинский совет rhinitis medicamentosa nasal congestion otrivin nasal mucosa inflammation local decongestants |
author_facet |
A. I. Kryukov A. B. Turovskiy I. G. Kolbanova K. M. Musayev A. B. Karasov |
author_sort |
A. I. Kryukov |
title |
Rhinitis medicamentosa – preventable disease |
title_short |
Rhinitis medicamentosa – preventable disease |
title_full |
Rhinitis medicamentosa – preventable disease |
title_fullStr |
Rhinitis medicamentosa – preventable disease |
title_full_unstemmed |
Rhinitis medicamentosa – preventable disease |
title_sort |
rhinitis medicamentosa – preventable disease |
publisher |
Remedium Group LLC |
series |
Медицинский совет |
issn |
2079-701X 2658-5790 |
publishDate |
2019-11-01 |
description |
Aim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa. The comparative estimation of modern means of pharmacotherapy was made. On the basis of literature and clinical research data, it is concluded that Otrivin has a much more gentle effect and contributes less to the development of rhinitis medicamentosa. |
topic |
rhinitis medicamentosa nasal congestion otrivin nasal mucosa inflammation local decongestants |
url |
https://www.med-sovet.pro/jour/article/view/4354 |
work_keys_str_mv |
AT aikryukov rhinitismedicamentosapreventabledisease AT abturovskiy rhinitismedicamentosapreventabledisease AT igkolbanova rhinitismedicamentosapreventabledisease AT kmmusayev rhinitismedicamentosapreventabledisease AT abkarasov rhinitismedicamentosapreventabledisease |
_version_ |
1721273673984245760 |